16th Dec 2019 10:01
(Alliance News) - Microsaic Systems PLC on Monday said it has partnered with Centre for Process Innovation to demonstrate the potential use of Microsaic's mass spectrometry instruments in bioprocessing.
The stock was 9.8% higher in London in morning trade at 1.18 pence a share.
The Centre for Process Innovation connects academia, businesses and funders to bring "bright ideas" and research into the marketplace.
The AIM-listed scientific technology company said the project will take about 12 months, starting in January 2020, and is expected to deliver an on-line, and real-time method for bioreactor chemical analysis and control.
"We are not aware of any other technology which can measure simultaneously small and large molecules in-situ, enabling real-time bioreactor control within a closed loop system," said Microsaic Chief Executive Glenn Tracey.
"Ongoing market and customer feedback reassures us that our offering is ahead of all others in the field, and the point-of-need differentiation utilising our proprietary miniaturised technology positions Microsaic favourably to gain traction in this new, high-growth application area," added Tracey.
By Evelina Grecenko; [email protected]
Copyright 2019 Alliance News Limited. All Rights Reserved.
Related Shares:
Microsaic